Obesity Medicine

Latest News

Investigational Keto Diet Pill Shows Promise in Phase 1 Trial: Daily Dose / image credit: ©New Africa/AdobeStock
Investigational Keto Diet Pill Shows Promise in Phase 1 Trial: Daily Dose

March 21st 2025

Your daily dose of the clinical news you may have missed.

ZUPREME-1 Phase 2b Trial of Petrelentide for Obesity Completes Enrollment / image credit ©Vitalii Vodolazskyi/stock.adobe.com
ZUPREME-1 Phase 2b Trial of Petrelentide for Obesity Completes Enrollment

March 19th 2025

Cost of Semaglutide, Tirzepatide Prohibitive Despite Significant Benefits
Cost of Semaglutide, Tirzepatide Prohibitive Despite Significant Benefits

March 14th 2025

CagriSema Phase 3 Update: Weight Loss of Nearly 16% Seen in REDEFINE 2 Trial /  image credit  Novo logo ©JHVE photo/stock.adobe.com
CagriSema Phase 3 Update: Weight Loss of Nearly 16% Seen in REDEFINE 2 Trial

March 11th 2025

Investigational Ketogenic Diet Pill BL-001 Shows Significant Weight Loss in Phase 1 Trial
Investigational Ketogenic Diet Pill BL-001 Shows Significant Weight Loss in Phase 1 Trial

March 5th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.